Fragile X gene expansions are not associated with dementia

Neurobiology of Aging

Volumn 35, Issue 11, 2014, Pages 2637-2638

  Hall, Deborah A ^a   Bennett, David A ^b   Filley, Christopher M ^c,d   Shah, Raj C ^b   Kluger, Benzi ^c   Ouyang, Bichun ^a   Berry Kravis, Elizabeth ^a,e  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e RUSH UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; FMR1; Fragile X

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; FMR1 PROTEIN, HUMAN;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; FMR1 GENE; GENE AND NUCLEIC ACID PARAMETERS; GENE EXPANSION; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; GENOME SIZE; HUMAN; MAJOR CLINICAL STUDY; MILD COGNITIVE IMPAIRMENT; COHORT ANALYSIS; GENETICS; TRINUCLEOTIDE REPEAT;

ALZHEIMER DISEASE; COHORT STUDIES; FRAGILE X MENTAL RETARDATION PROTEIN; GENETIC TESTING; HUMANS; MILD COGNITIVE IMPAIRMENT; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84917699896     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.04.027     Document Type: Article

References (5)

1. Hall D.A., Berry-Kravis E., Jacquemont S., Rice C.D., Cogswell J.B., Zhang L. Prior diagnoses given to persons with the fragile X-associated tremor/ataxia syndrome. Neurology 2005, 65:299-301.
2. Rodriguez-Revenga L., Santos M.M., Sánchez A., Pujol M., Gómez-Anson B., Badenas C., Jiménez D., Madrigal I., Milà M. Screening for FXTAS in 95 Spanish patients negative for Huntington disease. Genet. Test. 2008, 12:135-138.
3. Seritan A.L., Nguyen D.V., Farias S.T., Hinton L., Grigsby J., Bourgeois J.A., Hagerman R.J. Dementia in fragile X-associated tremor/ataxia syndrome (FXTAS): comparison with Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B:1138-1144.
4. Sokol D.K., Maloney B., Long J.M., Ray B., Lahiri D.K. Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links. Neurology 2011, 76:1344-1352.
5. Tassone F., Greco C.M., Hunsaker M.R., Seritan A.L., Berman R.F., Gane L.W., Jacquemont S., Basuta K., Jin L.W., Hagerman P.J., Hagerman R.J. Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav. 2012, 11:577-585.